Laura Palmeri

2.7k total citations
20 papers, 390 citations indexed

About

Laura Palmeri is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Laura Palmeri has authored 20 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Laura Palmeri's work include Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Genomics and Diagnostics (3 papers). Laura Palmeri is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Genomics and Diagnostics (3 papers). Laura Palmeri collaborates with scholars based in Italy and United States. Laura Palmeri's co-authors include S. Palmeri, Andrea Sartore‐Bianchi, Salvatore Siena, Katia Bencardino, Alessio Amatu, Gianluca Mauri, Federica Tosi, Erica Bonazzina, Antonio Craxı̀ and Alberto Bardelli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Laura Palmeri

20 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Palmeri Italy 12 285 130 101 85 85 20 390
Irfan Firdaus United States 9 303 1.1× 185 1.4× 82 0.8× 214 2.5× 50 0.6× 15 479
N J Agnantis Greece 13 223 0.8× 69 0.5× 82 0.8× 169 2.0× 87 1.0× 24 429
Ricardo Alvarez United States 11 133 0.5× 98 0.8× 65 0.6× 92 1.1× 58 0.7× 20 374
Yuji Shimoda Japan 10 210 0.7× 132 1.0× 99 1.0× 133 1.6× 229 2.7× 26 410
Eriko Aimono Japan 12 192 0.7× 128 1.0× 82 0.8× 84 1.0× 118 1.4× 40 374
Bérengère Dadone France 11 120 0.4× 172 1.3× 64 0.6× 178 2.1× 102 1.2× 17 377
Dimitrios Krikelis Greece 13 227 0.8× 152 1.2× 86 0.9× 167 2.0× 103 1.2× 21 441
T. Macarulla Mercadé Spain 12 296 1.0× 128 1.0× 37 0.4× 147 1.7× 68 0.8× 60 459
Vadim Baykov Russia 11 207 0.7× 34 0.3× 118 1.2× 163 1.9× 50 0.6× 47 480
Nicole Kelbick United States 7 260 0.9× 94 0.7× 95 0.9× 158 1.9× 101 1.2× 9 522

Countries citing papers authored by Laura Palmeri

Since Specialization
Citations

This map shows the geographic impact of Laura Palmeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Palmeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Palmeri more than expected).

Fields of papers citing papers by Laura Palmeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Palmeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Palmeri. The network helps show where Laura Palmeri may publish in the future.

Co-authorship network of co-authors of Laura Palmeri

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Palmeri. A scholar is included among the top collaborators of Laura Palmeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Palmeri. Laura Palmeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palmeri, Laura, et al.. (2023). Reporting of patient reported outcomes in randomized clinical trials (RCTs) in non-small cell lung cancer (NSCLC) patients (pts).. Journal of Clinical Oncology. 41(16_suppl). 6573–6573. 1 indexed citations
2.
Palmeri, Laura, et al.. (2022). Oncology clinical trial termination trends: Analysis across the prior 20 years.. Journal of Clinical Oncology. 40(16_suppl). e13602–e13602. 1 indexed citations
3.
Mauri, Gianluca, Elio Gregory Pizzutilo, Alessio Amatu, et al.. (2018). Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies. Cancer Treatment Reviews. 73. 41–53. 65 indexed citations
4.
Siena, Salvatore, Andrea Sartore‐Bianchi, Livio Trusolino, et al.. (2017). Abstract CT005: Final results of the HERACLES trial in HER2-amplified colorectal cancer. Cancer Research. 77(13_Supplement). CT005–CT005. 18 indexed citations
5.
Siena, Salvatore, Andrea Sartore‐Bianchi, Livio Trusolino, et al.. (2016). Final Results of the HERACLES trial in HER2 amplified colorectal cancer. Annals of Oncology. 27. iv39–iv39. 12 indexed citations
6.
Bencardino, Katia, Gianluca Mauri, Alessio Amatu, et al.. (2016). Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge: Single Institution Series and Systematic Review Study. Clinical Colorectal Cancer. 15(3). 213–221. 26 indexed citations
7.
Braud, Filippo de, Monica Niger, Silvia Damian, et al.. (2015). Alka-372-001: First-in-human, phase I study of entrectinib – an oral pan-trk, ROS1, and ALK inhibitor – in patients with advanced solid tumors with relevant molecular alterations.. Journal of Clinical Oncology. 33(15_suppl). 2517–2517. 41 indexed citations
8.
Braud, Filippo de, Lorenzo Pilla, Monica Niger, et al.. (2014). Rxdx-101, an Oral Pan-Trk, Ros1, and Alk Inhibitor, in Patients with Advanced Solid Tumors with Relevant Molecular Alterations. Annals of Oncology. 25. iv148–iv148. 7 indexed citations
9.
Braud, Filippo de, Lorenzo Pilla, Monica Niger, et al.. (2014). Phase 1 open label, dose escalation study of RXDX101, an oral pan-trk, ROS1, and ALK inhibitor, in patients with advanced solid tumors with relevant molecular alterations.. Journal of Clinical Oncology. 32(15_suppl). 2502–2502. 27 indexed citations
10.
Palmeri, S., Massimiliano Berretta, & Laura Palmeri. (2013). Medical Treatment Of Elderly Patients With Breast Cancer. Anti-Cancer Agents in Medicinal Chemistry. 13(9). 1325–1331. 3 indexed citations
11.
Cabibbo, Giuseppe, Laura Palmeri, S. Palmeri, & Antonio Craxı̀. (2011). Should cirrhosis change our attitude towards treating non‐hepatic cancer?. Liver International. 32(1). 21–27. 22 indexed citations
12.
Comella, Pasquale, Vincenzo Emanuele Chiurì, Giuseppe De Cataldis, et al.. (2009). Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancer. Lung Cancer. 68(1). 94–98. 5 indexed citations
13.
Raimondi, Cristina, et al.. (2009). [Role of loco-regional treatments for patients with breast cancer liver metastases].. PubMed. 100(9). 424–33. 1 indexed citations
14.
Palmeri, Laura. (2008). Weekly docetaxel in the treatment of metastatic breast cancer. Therapeutics and Clinical Risk Management. Volume 4(5). 1047–1059. 18 indexed citations
15.
Palmeri, S., Vito Lorusso, Laura Palmeri, et al.. (2006). Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site. Cancer. 107(12). 2898–2905. 34 indexed citations
16.
Scola, Letizia, Antonino Crivello, Laura Palmeri, et al.. (2006). Cytokine Gene Polymorphisms and Breast Cancer Susceptibility. Annals of the New York Academy of Sciences. 1089(1). 104–109. 38 indexed citations
17.
Boccardo, Francesco & Laura Palmeri. (2006). Adjuvant chemotherapy of bladder cancer. Annals of Oncology. 17. v129–v132. 11 indexed citations
18.
Crivello, Antonino, Letizia Scola, Giusi Irma Forte, et al.. (2006). Regulatory Cytokine Gene Polymorphisms and Risk of Colorectal Carcinoma. Annals of the New York Academy of Sciences. 1089(1). 98–103. 40 indexed citations
19.
Palmeri, S., Stefano Spada, Gianfranco Filippelli, et al.. (2005). Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study. Oncology. 68(4-6). 438–445. 16 indexed citations
20.
Bellavia, Daniele, et al.. (2004). Improved resolution power of electrophoretic fractionation of DNA using a voltage gradient “up and down” application. Electrophoresis. 25(17). 2932–2934. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irfan Firdaus Breakdown of academic impact, for papers by N J Agnantis Breakdown of academic impact, for papers by Ricardo Alvarez Breakdown of academic impact, for papers by Yuji Shimoda Breakdown of academic impact, for papers by Eriko Aimono Breakdown of academic impact, for papers by Bérengère Dadone Breakdown of academic impact, for papers by Dimitrios Krikelis Breakdown of academic impact, for papers by T. Macarulla Mercadé Breakdown of academic impact, for papers by Vadim Baykov Breakdown of academic impact, for papers by Nicole Kelbick
Rankless by CCL
2026